|
Dr. Lee joined Cougar Biotechnology in November 2004 as Vice President of Clinical Research and Development. Prior to Cougar, Dr. Lee was Senior Director, Clinical Development-Oncology at Chiron Corporation since 2003. Prior to Chiron, Dr. Lee was Senior Therapeutic Expert in Oncology at Hoffman La Roche from 1999 to 2003. Dr Lee also served in a variety of clinical development positions at Rhone Poulenc Rorer (now Aventis) from 1994 through 1999 including the position of Associate Director of Medical Affairs where Dr. Lee was responsible for the clinical development of the anticancer drug Taxotere in breast cancer.
Dr. Lee is a board certified medical oncologist and holds an M.D. from The University of Miami School of Medicine and a Ph.D. in molecular biology from Columbia University.
| 